English Convenience Translation - the German language is decisive

Annual General Meeting of BioNTech SE on 17 May 2024

Proposal on the appropriation of balance sheet profit for the 2023 financial year

The Management Board proposes to carry forward the balance sheet profit of BioNTech SE from the past 2023 financial year in the amount of EUR 9.360.948.811,25 in full to new account.

Mainz, in March 2024

BioNTech SE

Management Board

_________________________________

_________________________________

Prof. Dr. med. Uğur Şahin

Jens Holstein

_________________________________

_________________________________

Sean Marett

Dr. Sierk Poetting

_________________________________

_________________________________

Ryan Richardson

Dr. James Ryan

_________________________________

Prof. Dr. med. Özlem Türeci

Attachments

Disclaimer

BioNTech SE published this content on 03 May 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 May 2024 00:20:07 UTC.